(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1H-benzo[d][1,3]oxazin-2(4H)-one-13C6; (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one-13C6; DMP 266-13C6; L 743726-13C6; Stocrin-13C6; Sustiva-13C6;
Efavirenz-13C6 is a fully characterized chemical compound used as a reference standard of API Efavirenz. The standard offered is compliant with regulatory guidelines. Efavirenz-13C6 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1261394-62-0
